Moreover the study population varies because of the different inclusion criteria (VISEP study was severe sepsis/septic shock excluding sepsis with a lesser degree of severity; mean SOFA95%5% CI): VISEP 7.8 (7.4 to 8.1) versus 7.3 (6.8 to 7.7) in our patients).
The ICUs were heterogeneous (severity, mean workload, volume, specialisation, caregiver/bed ratios).
Persons with MD had a mean age of 53.9 years (SD = 11.0, 76% female) and had moderate to high depression severity (mean HDRS 21.7, sd = 4.4).
One small sham-controlled trial found no difference between moxibustion and sham control in symptom severity (mean difference 0.35, 95% CI [−0.77, 1.47]).
Furthermore, these participants experienced a greater reduction in mental illness symptom severity (mean change from baseline: −2.56 vs. -6.26, p = 0.043) (Additional file 2: Table S2).
Our pooled analysis confirmed statistically significant associations for dementia, illness severity (mean APACHE II score), urinary catheterisation, polypharmacy, albumin level and length of hospital stay.
Depletion of peripheral monocytes with etoposide resulted in a remarkable reduction in the frequency and severity of synovial inflammation, since only one out of 12 mice (8%, severity mean 0.5 ± 0.2) developed arthritis.
The highest scores were assigned to the criteria "Relevance and validity of evidence" (mean 2.5, SD 0.3, on a scale of 0 to 3) and "Disease severity" (mean 2.2, SD 0.4).
Analogously, injection of LMW-uPA into SCID mice lacking functional T lymphocytes and B lymphocytes resulted in arthritis only in two out of eight mice (25%, severity mean 0.75 ± 0.15).
Our initial analysis revealed that in patients administered DrotAA, two baseline measures of severity – mean number of organ dysfunctions and APACHE II score – and two dynamic laboratory measures – serum creatinine and platelet count – were associated with 28-day mortality.
